Korsana Biosciences
PrivateLast Round
PIPE
Apr 1, 2026
Total Funding Raised
$425M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Korsana Biosciences is a biotechnology company developing brain-penetrant therapeutics for neurodegenerative diseases using its proprietary blood-brain barrier shuttle platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Korsana Biosciences Comparables
Compare Korsana Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NanoNewron, Inc. | 81% | |
| AbbVie | 78% | |
| SciNeuro Pharmaceuticals | 76% |
Korsana Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| PIPE | Apr 1, 2026 | ||||
| Seed | Feb 18, 2026 | ||||
| Series A | Sep 1, 2025 | ||||
| Seed | Dec 1, 2024 |
Key People
Founding team and executive leadership
Korsana Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | PIPE, Seed, Series A |
| RA Capital Management | PIPE |
| TCG Crossover | PIPE, Seed, Series A |
| Forbion | PIPE |
| Fairmount Funds Management | Seed, PIPE |
| Commodore Capital | PIPE |
| Kalehua Capital Management | PIPE |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 110% MoM, reaching 3.9K.
- Aug 1, 2026
Grew 27% QoQ from 22 to 28 employees.
Recent news
Latest coverage and updates
- receives_financingSep 8, 2026
Korsana Biosciences, Inc. received financing of $380M in private financing on Sep 8th '26.
Korsana Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Korsana Biosciences's valuation, stock price, and market status.
Is Korsana Biosciences a public or private company?
Korsana Biosciences is a private company.
What is the current stock price of Korsana Biosciences?
Korsana Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Korsana Biosciences worth (valuation)?
Valuation information for Korsana Biosciences is not publicly available.
Can I buy Korsana Biosciences stock?
Korsana Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Korsana Biosciences's last funding round?
Korsana Biosciences's most recent funding round was Seed on February 18, 2026.
Who are the main investors in Korsana Biosciences?
Key investors in Korsana Biosciences include TCG Crossover, Wellington Management.
Will Korsana Biosciences IPO soon?
No public IPO plans have been announced for Korsana Biosciences.
How can I track Korsana Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Korsana Biosciences's secondary market activity and sign up for updates.